Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03086486
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:05.810734+00:00
Published At
2023-06-29T00:00:00+00:00
Record Updated At
2023-06-29
Results Posted At
2023-06-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Tuberculosis, Pulmonary", "Tuberculosis, Multidrug-Resistant", "Tuberculosis, MDR", "Tuberculosis", "Extensively Drug-Resistant Tuberculosis", "Pre-XDR-TB", "XDR-TB"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-29"
protocolSection.identificationModule.nctId
"NCT03086486"
protocolSection.identificationModule.officialTitle
"A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-06-29"

Study condition terms

  • Tuberculosis, Pulmonary (protocolSection.conditionsModule.conditions)
  • Tuberculosis, Multidrug-Resistant (protocolSection.conditionsModule.conditions)
  • Tuberculosis, MDR (protocolSection.conditionsModule.conditions)
  • Tuberculosis (protocolSection.conditionsModule.conditions)
  • Extensively Drug-Resistant Tuberculosis (protocolSection.conditionsModule.conditions)
  • Pre-XDR-TB (protocolSection.conditionsModule.conditions)
  • XDR-TB (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.